Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

ABHD17B Knockout Hela Polyclonal Cells

ABHD17B Knockout Hela Polyclonal Cells is a knockout polyclonal cell population. The ABHD17B was knocked out in the Hela cells using the CRISPR RNP technique.
Cat. No. ARG20253

ATG7 Knockout K562 Polyclonal Cells

ATG7 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG7 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20252

ATG5 Knockout K562 Polyclonal Cells

ATG5 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG5 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20251

ATG4C Knockout K562 Polyclonal Cells

ATG4C Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG4C was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20250

ATG4B Knockout K562 Polyclonal Cells

ATG4B Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG4B was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20249

ATG4A Knockout K562 Polyclonal Cells

ATG4A Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG4A was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20248

ATG2B Knockout K562 Polyclonal Cells

ATG2B Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG2B was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20247

ATG2A Knockout K562 Polyclonal Cells

ATG2A Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG2A was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20246

ATG16L1 Knockout K562 Polyclonal Cells

ATG16L1 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG16L1 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20245

ATG14 Knockout K562 Polyclonal Cells

ATG14 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG14 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20244

ATG13 Knockout K562 Polyclonal Cells

ATG13 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The ATG13 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG20243

ABHD16A Knockout Hela Polyclonal Cells

ABHD16A Knockout Hela Polyclonal Cells is a knockout polyclonal cell population. The ABHD16A was knocked out in the Hela cells using the CRISPR RNP technique.
Cat. No. ARG20242

Loading products...